Rocket


News + Filings
Transactions





Michelon Francois Roger

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
01/30/2023ENDRA Life Sciences Inc.NDRAGrantStock Options69.5k$4.02$279.5k 01/30/2023
03/28/2022ENDRA Life Sciences Inc.NDRAGrantStock Options713.1k$0.38$271k 03/28/2022
04/05/2021ENDRA Life Sciences Inc.NDRAGrantStock Options50k$2.64$132k 04/05/2021
12/04/2020ENDRA Life Sciences Inc.NDRASaleCommon Stock71.5k$0.83$59.4k 12/04/2020
06/23/2020ENDRA Life Sciences Inc.NDRAExercise (in-the-money or at-the-money)Warrants2.9k$0.87$2.5k 06/23/2020
06/08/2020ENDRA Life Sciences Inc.NDRAConversionSeries A Convertible Preferred Stock4.372$1,143.68$5k 06/08/2020
06/08/2020ENDRA Life Sciences Inc.NDRAConversionCommon Stock5.2k$0.87$4.5k 06/08/2020
04/09/2020ENDRA Life Sciences Inc.NDRAGrantCommon Stock123.1k$0.00$0 04/09/2020
12/11/2019ENDRA Life Sciences Inc.NDRAGrantWarrants5k$0.87$4.4k 12/11/2019
12/11/2019ENDRA Life Sciences Inc.NDRAGrantSeries A Convertible Preferred Stock4.372$1,143.68$5k 12/11/2019
12/11/2019ENDRA Life Sciences Inc.NDRAGrantStock option (right to buy)612k$0.90$550.8k 12/11/2019
12/13/2018ENDRA Life Sciences Inc.NDRAGrantStock Options125k$2.25$281.2k 12/13/2018
11/13/2018ENDRA Life Sciences Inc.NDRAConversionConvertible Promissory Note0$1.68$0 11/13/2018
11/13/2018ENDRA Life Sciences Inc.NDRAConversionCommon Stock6k$1.68$10k 11/13/2018
06/28/2018ENDRA Life Sciences Inc.NDRAGrantWarrants2.5k$2.52$6.2k 06/28/2018
06/28/2018ENDRA Life Sciences Inc.NDRAGrantConvertible Promissory Note0$10,000.00$0 06/28/2018
06/09/2017ENDRA Life Sciences Inc.NDRAGrantStock Options32k$4.55$145.4k 06/09/2017
06/09/2017ENDRA Life Sciences Inc.NDRAGrantStock Options32k$4.55$145.4k 06/09/2017
05/12/2017ENDRA Life Sciences Inc.NDRAConversionCommon Stock26.5k$1.40$37.2k 05/12/2017
05/12/2017ENDRA Life Sciences Inc.NDRAConversionConvertible Promissory Note0$1.40$0 05/12/2017
05/12/2017ENDRA Life Sciences Inc.NDRAGrantStock Options307.3k$5.00$1.5M 05/12/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy